Refeyn, the company behind pioneering mass photometry technology, has announced the installation of the 500th system based on its novel single-particle bioanalytical technology - notably, within just ...

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced presentation of analyses of its previous Phase 3 program evaluating ampreloxetine, an ...

YUPELRI® (revefenacin) net sales of $58.3 million, recognized by Viatris, increased 6% versus Q1 20241 TRELEGY net sales of $854M, as reported by GSK, increased ...

Indian biopharma firm Biocon's profit more than doubled in the fourth quarter, led by strong demand for its generics and biosimilar drugs in its key U.S. and European markets.

The company added to a recent flurry of pledges by pharmaceutical companies, promising $11 billion in new capital and ...

The maker of Ozempic and Wegovy expects lower sales and profit growth this year despite recent victories against compounders.

AJICAP® Antibody-Drug Conjugate Manufacturing Technology Contributes to Enhanced Efficacy of Antibody DrugsTOKYO, May 7, 2025 ...